Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Holding(s) in Company

20 Apr 2020 16:49

RNS Number : 2529K
Oxford Biomedica PLC
20 April 2020
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biomedica Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

M&G Plc

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

17/04/2020

6. Date on which issuer notified (DD/MM/YYYY):

20/04/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

14.90%

0.00%

14.90%

76,907,779

Position of previous notification (if

applicable)

15.06%

0.00%

15.06%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD GBP0.50

GB00BDFBVT43

11,460,464

14.90%

SUBTOTAL 8. A

11,460,464

14.90%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

SUBTOTAL 8.B.2

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

M&G Plc (Parent Company)

14.90%

0.00%

14.90%

M&G Group Limited

(wholly owned subsidiary of M&G Plc)

14.90%

0.00%

14.90%

M&G FA Limited

(wholly owned subsidiary of M&G Group Limited)

14.90%

0.00%

14.90%

M&G Investment

Management Limited

(wholly owned subsidiary of M&G FA Limited)

14.90%

0.00%

14.90%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

 

 

Place of completion

London, United Kingdom

Date of completion

20th April 2020

 

Contact name:

Natalie Walter

Contact telephone number:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLURSVRRBUSUAR
Date   Source Headline
2nd Jun 20267:00 amRNSOXB Capital Markets Event
1st Jun 20267:00 amRNSTotal Voting Rights
27th May 20267:00 amRNSDirector Declaration
22nd May 20262:17 pmRNSDirector/PDMR Shareholding
19th May 20269:56 amRNSPDMR Dealing
13th May 202610:52 amRNSPDMR Dealing
7th May 20264:58 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20268:15 amRNSAdmission to Trading
27th Apr 20269:51 amRNSAdmission to Trading Application
13th Apr 20267:00 amRNS-RLaunch of viral vector fast-track offering
8th Apr 20265:18 pmRNSGrant of Awards
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20263:30 pmRNS2026 Annual General Meeting notification
26th Mar 20267:00 amRNSPreliminary results for the year ended 31 Dec 2025
18th Mar 20267:00 amRNS-RLicensing agreement with VVMF
9th Mar 20267:53 amRNSAdmission to Trading
4th Mar 202611:45 amRNSAdmission to Trading Application
3rd Mar 20267:00 amRNSCapital Markets Day and investor conferences
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20261:31 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
26th Feb 20261:49 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 202612:33 pmRNSForm 8.3 - Oxford Biomedica plc
26th Feb 202611:09 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
26th Feb 202611:08 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
26th Feb 20269:42 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica plc
25th Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
25th Feb 20262:32 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
25th Feb 202612:33 pmRNSResponse to Rule 2.8 Announcement
25th Feb 202612:12 pmRNSDisclosure Table
25th Feb 202612:00 pmRNSRule 2.8 Announcement
25th Feb 202611:46 amRNSForm 8.3 - Oxford Biomedica plc
25th Feb 202610:53 amRNSForm 8.5 (EPT/NON-RI) Oxford Biomedica Plc
25th Feb 202610:17 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
25th Feb 202610:15 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
24th Feb 20267:29 amRNSForm 8.5 (EPT/RI)-Oxford Biomedica plc
24th Feb 20267:25 amRNSForm 8.5 (EPT/NON-RI)-Oxford Biomedica plc
24th Feb 20267:03 amRNSFull year Trading Update and Notice of Results
23rd Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
23rd Feb 20262:20 pmEQSForm 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc
23rd Feb 20267:40 amRNSForm 8.5 (EPT/RI)-Oxford Biomedica plc
23rd Feb 20267:39 amRNSForm 8.5 (EPT/NON-RI)-Oxford Biomedica plc
20th Feb 20263:20 pmRNSForm 8.3 - Oxford Biomedica plc
20th Feb 20261:46 pmRNSForm 8.3 - Oxford Biomedica Plc
20th Feb 20268:13 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc
20th Feb 20268:08 amRNSForm 8.5 (EPT/NON-RI) - Oxford Biomedica plc
19th Feb 20262:39 pmRNSForm 8.5 (EPT/RI)-Replacement of Oxford Biomedica
19th Feb 20269:44 amRNSRule 2.9 Announcement
19th Feb 20268:04 amRNSForm 8.5 (EPT/RI) - Oxford Biomedica plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.